Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 13/20 | 0.67 |
| ▸ | OPRK1 | P41145 | 4/20 | 0.56 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.56 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Niravoline SCHEMBL29388767 | 1.00 | SIGMAR1 (0.67) | SIGMAR1OPRK1OPRM1OPRD1 | |
| Niravoline SCHEMBL637489 | 1.00 | SIGMAR1 (0.67) | SIGMAR1OPRK1OPRM1OPRD1 | |
| Niravoline SCHEMBL9250990 | 1.00 | SIGMAR1 (0.67) | SIGMAR1OPRK1OPRM1OPRD1 | |
| Niravoline SCHEMBL7942442 | 0.99 | SIGMAR1 (0.66) | SIGMAR1OPRK1OPRM1OPRD1 | |
| Niravoline SCHEMBL7747722 | 0.99 | SIGMAR1 (0.66) | SIGMAR1OPRK1OPRM1OPRD1 | |
| SCHEMBL9260449 | 0.90 | SIGMAR1 (0.64) | SIGMAR1OPRK1OPRM1OPRD1 | |
| SCHEMBL9510530 | 0.90 | SIGMAR1 (0.64) | SIGMAR1OPRK1OPRM1OPRD1 | |
| SCHEMBL7966344 | 0.90 | SIGMAR1 (0.64) | SIGMAR1OPRK1OPRM1OPRD1 | |
| SCHEMBL9644180 | 0.90 | SIGMAR1 (0.64) | SIGMAR1OPRK1OPRM1OPRD1 | |
| SCHEMBL9512728 | 0.88 | SIGMAR1 (0.64) | SIGMAR1OPRK1OPRM1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6174878-B1 | OR INTRANASAL COMPOSITION E.G., ASIMADOLINE (EMD-61753), ENADOLINE, BENZENEACETAMIDE, AS AN ANALGESIC FOR EAR INFECTION, SWIMMER'S EAR, ETC.; ACTIVATION OF SPECIFIC RECEPTORS SO NO SIDE EFFECTS | ALCON LABORATORIES, INC. | 2001-01-16 | — | — | US | claimed |
| US-5348971-A | Indanes useful as analgesics | ROUSSEL UCLAF (FR) | 1994-09-20 | — | — | US | claimed |
| EP-0374054-B1 | INDANE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND INTERMEDIATES OBTAINED, THEIR USE AS MEDICINES, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ROUSSEL-UCLAF (FR) | 1993-10-06 | — | — | EP | claimed |
| US-6271395-B1 | E.G.,(.+-.)-N-(2,3-DIHYDRO-2-(1-PYRROLIDINYL)-1H-INDEN-1-Y1) -2 ,4-DINITRO-N-METHYL-BENZENE-ACETAMIDE; STRONG AFFINITY FOR OPTICAL RECEPTORS, CENTRAL ANALGESIC, DIURETIC, ANTIARRYTHMIC, HYPOTENSIVE AND ANTIISCHEMIC ACTIVITY. | HOECHST MARION ROUSSOL (FR) | 2001-08-07 | — | — | US | disclosed |
| US-6268359-B1 | Preventives or remedies for vision disorders | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2001-07-31 | — | — | US | disclosed |
| US-6174878-B1 | OR INTRANASAL COMPOSITION E.G., ASIMADOLINE (EMD-61753), ENADOLINE, BENZENEACETAMIDE, AS AN ANALGESIC FOR EAR INFECTION, SWIMMER'S EAR, ETC.; ACTIVATION OF SPECIFIC RECEPTORS SO NO SIDE EFFECTS | ALCON LABORATORIES, INC. | 2001-01-16 | — | — | US | disclosed |
| EP-1050308-A1 | PREVENTIVES OR REMEDIES FOR VISION DISORDERS | Senju Pharmaceutical Co., Ltd. (JP) | 2000-11-08 | — | — | EP | disclosed |
| US-5436244-A | Antiarrhythmia agents | ROUSSEL UCLAF (FR) | 1995-07-25 | — | — | US | disclosed |
| US-5348971-A | Indanes useful as analgesics | ROUSSEL UCLAF (FR) | 1994-09-20 | — | — | US | disclosed |
| EP-0374054-B1 | INDANE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND INTERMEDIATES OBTAINED, THEIR USE AS MEDICINES, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ROUSSEL-UCLAF (FR) | 1993-10-06 | — | — | EP | disclosed |